Windtree Therapeutics
14 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C (NCT05975021) | Windtree Therapeutics | 2024-06-01 |
| The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) (NCT04389671) | Windtree Therapeutics | 2021-01-05 |
| The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (NCT04325035) | Windtree Therapeutics | 2020-09-28 |
| A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age (NCT04264156) | Windtree Therapeutics | 2020-04-18 |
Track Windtree Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.